Bluejay Diagnostics, Inc. (BJDX) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Bluejay Diagnostics, Inc. (BJDX) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $970,578, listed on NASDAQ, employing roughly 7 people, carrying a beta of 0.82 to the broader market. Bluejay Diagnostics, Inc. Led by Indranil Dey, public since 2021-11-10.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for BJDX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →